Advertisement

Topics

Millennium Research Group (MRG) Company Profile

19:11 EST 10th December 2018 | BioPortfolio

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.


News Articles [1039 Associated News Articles listed on BioPortfolio]

QIAGEN: Short-Engagement von Millennium International Management gesteigert

KJ Venlo (www.aktiencheck.de) - Leerverkäufer Millennium International Management LP erhöht Netto-Leerverkaufsposition in Aktien der QIAGEN N.V. geringfügig: Die Hedgefonds-Manager von Millennium I...

Millennium:Looking for First in Class and Best in Class Opportunities in Oncology and Hematology

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Dan Curran, Vice President, Corporate Development at Millennium

QIAGEN: Short-Engagement von Millennium International Management weiter gesteigert

KJ Venlo (www.aktiencheck.de) - Leerverkäufer Millennium International Management LP hebt Netto-Leerverkaufsposition in Aktien der QIAGEN N.V. wieder an: Die Leerverkäufer-Attacke des Hedgefonds Mi....

QIAGEN: Leerverkäufer Millennium International Management bleibt im Rückwärtsgang

KJ Venlo (www.aktiencheck.de) - Leerverkäufer Millennium International Management LP verringert Netto-Leerverkaufsposition in Aktien der QIAGEN N.V. wieder sichtbar: Die Leerverkäufer des Hedgefond....

QIAGEN: Leerverkäufer Millennium International Management hält QIAGEN unter Beschuss

KJ Venlo (www.aktiencheck.de) - Leerverkäufer Millennium International Management LP erhöht Netto-Leerverkaufsposition in Aktien der QIAGEN N.V. deutlich: Die Leerverkäufer des Hedgefonds Millenniu...

Research group aims to offer more personalized treatments for pediatric cancers

A new Emmy Noether Independent Junior Research Group at Charité - Universitätsmedizin Berlin is studying the development of pediatric cancers. The research group is being funded by the German Resear...

The Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic across Europe

A new report, by Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation (AF), published... The post The Burden of Atrial Fibrillati...

Sareum and Structure: An Interview with Tim Mitchell, CEO

Fintan Walton talks to Tim Mitchell, CEO, Sareum, about founding the company with David Williams and John Reader, as a spin-out from Millennium Pharmaceuticals' Structure-based Discovery Department. T...

PubMed Articles [3172 Associated PubMed Articles listed on BioPortfolio]

Assessing the performance of the least developed countries in terms of the Millennium Development Goals.

This article presents a proposal for assessing the progress of least developed countries towards the achievement of the Millennium Development Goals over the period 2000-2015. Composite indices are bu...

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Impact of group practices on patients, physicians and healthcare systems: protocol for a scoping review.

Group practices have potential benefits for patients, physicians and healthcare systems. Although group practices have been around for many years, research in this area is lacking and generally is cen...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The Sustainable Development Goal for Urban Sanitation: Africa's Statistical Tragedy Continues?

Sanitation delivery in the urban areas of sub-Saharan African countries has been a chronic issue, particularly difficult to tackle. Under the Millennium Development Goals, the sanitation target in urb...

Clinical Trials [6260 Associated Clinical Trials listed on BioPortfolio]

The Millennium Villages Project: Assessing the Impact on Child Survival and the Millennium Development Goals in Sub-Saharan Africa

The Millennium Villages Project involves the coordinated and simultaneous delivery of a package of proven interventions in health, agriculture, infrastructure and education. The project wo...

MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age

This research study is evaluating drugs called Millennium 9708 (referred to as MLN9708) in combination with standard therapy for acute myeloid leukemia (AML) consisting of daunorubicin and...

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

This is a research study to see if a new drug called bortezomib is useful to treat multiple myeloma in people who are newly diagnosed, and have not yet received treatment for their disease...

Treating Sleep Problems in VA Adult Day Health Care

The Veterans Millennium Health Care and Benefits Act (Millennium Act) of 1999 mandated the Department of Veterans Affairs (VA) to provide non-institutional long-term care to veterans. Adul...

Research Participants' Perceptions of Their Experience in Clinical Studies

This study will examine how research volunteers experience their participation in studies in order to develop surveys to be used by research centers trying to improve the experience of the...

Companies [3083 Associated Companies listed on BioPortfolio]

Millennium Research Group (MRG)

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and ...

Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider o...

Millennium Dental Technologies, Inc.

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a first-in-class proteasome inhibitor, and has a robust cl...

Millennium: The Takeda Oncology Company

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, and has a robust clinical de...

Millennium Pharmaceuticals, Inc.

Millennium Pharmaceuticals, The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical developme...

More Information about "Millennium Research Group (MRG)" on BioPortfolio

We have published hundreds of Millennium Research Group (MRG) news stories on BioPortfolio along with dozens of Millennium Research Group (MRG) Clinical Trials and PubMed Articles about Millennium Research Group (MRG) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Millennium Research Group (MRG) Companies in our database. You can also find out about relevant Millennium Research Group (MRG) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record